Trial Profile
Phase 2 randomized double-blind placebo-controlled six weeks study of the efficacy and safety of tofimilast dry powder for inhalation in adults diagnosed with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2012
Price :
$35
*
At a glance
- Drugs Tofimilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Dec 2005 New trial record.